CAV1 and neoplasm: Furthermore, immunohistochemistry (IHC) analysis on tumor samples showed that the staining for Cav-1, a CHO-binding protein, and pAkt1 (Figure 4F) was completely absent in lovastatin-treated tumors compared to PBS-treated tumors (Figure 4G).